Byfavo

Active Ingredient(s): Remimazolam
FDA Approved: * July 2, 2020
Pharm Company: * COSMO TECHNOLOGIES LTD
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Byfavo Overview

Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less.[2][4][5] is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for m...

Read more Byfavo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Remimazolam

Recent Byfavo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Remimazolam
  • Injection: 20mg
  • Powder: 20mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Remimazolam or a similar ingredient: (1 result)